Literature DB >> 2147168

Down's syndrome with transient myeloproliferative syndrome.

I Al Mulhim1.   

Abstract

Two cases of Down's syndrome with high leukocyte count are being reported. Both patients had spontaneous remission without cytotoxic therapy.

Entities:  

Mesh：

Year:  1990        PMID： 2147168     DOI： 10.1007/bf02722097

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN： 0019-5456            Impact factor:   1.967


  8 in total

1.  Leukemia in Down's syndrome.

Authors:  M E LAHEY; F R BEIER; J F WILSON
Journal:  J Pediatr       Date:  1963-07       Impact factor: 4.406

2.  Ineffective regulation of granulopoiesis masquerading as congenital leukemia in a mongoloid child.

Authors:  J D ROSS; W C MOLONEY; J F DESFORGES
Journal:  J Pediatr       Date:  1963-07       Impact factor: 4.406

3.  Down's syndrome and acute leukemia: myeloblastic or lymphoblastic? Report of forty-three cases and review of the literature.

Authors:  F Rosner; S L Lee
Journal:  Am J Med       Date:  1972-08       Impact factor: 4.965

4.  Down syndrome and leukaemia.

Authors:  C A Stiller; L M Kinnier Wilson
Journal:  Lancet       Date:  1981-12-12       Impact factor: 79.321

5.  Transient myeloproliferative syndrome in a phenotypically normal infant.

Authors:  M D Hanna; S L Melvin; L W Dow; D Williams; G Dahl; J Mirro
Journal:  Am J Pediatr Hematol Oncol       Date:  1985

6.  Congenital leukemoid reaction followed by fatal leukemia. A case with Down's syndrome.

Authors:  H P Lin; H Menaka; K H Lim; H S Yong
Journal:  Am J Dis Child       Date:  1980-10

7.  Transient leukemoid reaction and trisomy 21 mosaicism in a phenotypically normal newborn.

Authors:  G M Brodeur; G V Dahl; D L Williams; R E Tipton; D K Kalwinsky
Journal:  Blood       Date:  1980-04       Impact factor: 22.113

8.  Infants with Down's syndrome. Use of cytogenetic studies and in vitro colony assay for granulocyte progenitor to distinguish acute nonlymphocytic leukemia from a transient myeloproliferative disorder.

Authors:  P A de Alarcon; S Patil; J Golberg; J B Allen; S Shaw
Journal:  Cancer       Date:  1987-09-01       Impact factor: 6.860
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.